Multiple Myeloma

Multiple Myeloma is a type of blood cancer that originates in plasma cells, a kind of white blood cell found in the bone marrow. These cells are responsible for producing antibodies to fight infections. In multiple myeloma, abnormal plasma cells multiply uncontrollably, crowding out healthy blood cells and producing a defective protein called monoclonal protein (M-protein) or paraprotein.

Key Points:

Cause: Exact cause is unknown, but risk factors include age (more common after 60), male
gender, African descent, family history, and exposure to certain chemicals/radiation.

Symptoms: Bone pain (especially in spine or chest) Fatigue and weakness (due to anemia) Frequent infections
High calcium levels (leading to confusion, constipation, or kidney issues) Kidney dysfunction

Diagnosis: Blood tests (for M-protein), urine tests, bone marrow biopsy, imaging (X-ray, MRI, CT).

Treatment: No permanent cure, but treatment can

manage symptoms: Chemotherapy Targeted therapy (e.g., proteasome inhibitors) Immunotherapy Steroids Stem cell transplant Bisphosphonates for bone health Let me know if you’d like this in a more patient-friendly or professional format.

Multiple Myeloma: Diagnosis & Treatment in India Multiple Myeloma is a type of blood cancer that affects plasma cells in the bone marrow. It disrupts the production of normal blood cells, leading to bone pain, fatigue, frequent infections, and kidney issues. Early diagnosis and specialized treatment are crucial for managing the
disease effectively. India offers world-class multiple myeloma treatment with advanced facilities, internationally trained oncologists, and cost-effective care. Popular treatment options include chemotherapy,
targeted therapy, immunotherapy, and stem cell transplants.

Why choose India for Multiple Myeloma treatment?

State-of-the-art cancer hospitals Affordable treatment packages No waiting period Comprehensive medical support and personalized care If you’re seeking trusted and affordable care abroad, consider India for high-quality Multiple Myeloma diagnosis and treatment.